Guobang Pharma Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	14,278	13,714	11,513	9,813	14,792	16,111
Market Cap Growth	34.90%	19.12%	17.32%	-33.66%	-8.19%	-
Enterprise Value	12,569	12,467	10,267	8,306	12,684	13,589
Last Close Price	25.82	24.80	20.23	16.76	24.60	26.56
PE Ratio	17.45	16.71	14.73	16.02	16.06	22.82
Forward PE	-	14.81	10.92	11.33	-	-
PS Ratio	2.38	2.28	1.95	1.83	2.59	3.58
PB Ratio	1.67	1.60	1.43	1.32	2.07	2.54
P/TBV Ratio	1.74	1.67	1.50	1.39	2.18	2.65
P/FCF Ratio	50.71	48.71	40.07	-	69.15	-
P/OCF Ratio	25.53	24.52	16.30	18.99	14.54	-
EV/Sales Ratio	2.09	2.07	1.74	1.55	2.22	3.02
EV/EBITDA Ratio	8.73	8.66	8.09	8.74	10.48	13.37
EV/EBIT Ratio	13.07	12.96	12.27	13.20	13.35	16.66
EV/FCF Ratio	44.64	44.28	35.74	-	59.29	-
Debt / Equity Ratio	0.12	0.12	0.10	0.13	0.09	0.03
Debt / EBITDA Ratio	0.69	0.69	0.61	1.02	0.55	0.17
Debt / FCF Ratio	3.52	3.52	2.72	-	3.11	-
Net Debt / Equity Ratio	-0.20	-0.20	-0.22	-0.21	-0.30	-0.31
Net Debt / EBITDA Ratio	-1.19	-1.19	-1.38	-1.67	-1.76	-1.95
Net Debt / FCF Ratio	-6.08	-6.08	-6.08	6.87	-9.98	3.18
Asset Turnover	0.55	0.55	0.56	0.55	0.69	0.69
Inventory Turnover	2.83	2.83	3.26	2.98	3.08	2.79
Quick Ratio	2.14	2.14	1.52	1.45	1.93	2.40
Current Ratio	3.18	3.18	2.30	2.22	2.75	3.96
Return on Equity (ROE)	9.85%	9.85%	10.08%	8.36%	13.64%	14.68%
Return on Assets (ROA)	5.52%	5.52%	4.95%	4.05%	7.17%	7.83%
Return on Invested Capital (ROIC)	11.92%	12.57%	12.11%	10.13%	18.00%	19.50%
Return on Capital Employed (ROCE)	10.60%	10.60%	10.20%	8.00%	13.20%	12.80%
Earnings Yield	5.75%	5.99%	6.79%	6.24%	6.23%	4.38%
FCF Yield	1.97%	2.05%	2.50%	-2.36%	1.45%	-3.88%
Dividend Yield	2.38%	-	2.99%	1.80%	2.44%	2.63%
Payout Ratio	43.81%	43.81%	24.83%	59.05%	13.92%	47.27%
Buyback Yield / Dilution	0.66%	0.66%	-0.27%	0.24%	-9.09%	-8.01%
Total Shareholder Return	3.04%	0.66%	2.73%	2.04%	-6.65%	-5.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.